S&P raises Susquehanna Health’s rating to ‘A+’

S&P Global Ratings has raised its long-term rating on Williamsport, Pa.-based Susquehanna Health’s $150 million of series 2009 bonds to “A+” from “A-.”

Advertisement

“The upgrade reflects Susquehanna’s anticipated Oct. 1, 2016, affiliation with ‘A+’ rated University of Pittsburgh Medical Center,” said S&P analyst Cynthia Keller. “Upon closing, University of Pittsburgh Medical Center is expected to assume responsibility for Susquehanna’s rated 2009 bonds as well as its other outstanding obligations, which we do not rate.”

The outlook is stable, reflecting UPMC’s excellent enterprise characteristics and the potential affiliation between the medical center and Susquehanna Health.

More articles on healthcare finance:
CRM is the new RCM: How strategic customer relationship management helps hospitals increase revenue and grow market share
For-profit hospital stock report: Week of Sept. 26-30
CMS to resume Medicare appeals settlements

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.